ImmunoCellular Therapeutics, Ltd. (IMUC) was a big mover last session, as its shares rose almost 41% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the volatile price range of $0.57 to $0.71 in the past one-month time frame.
Over the last 30 days, the company witnessed one positive estimate revision and the Zacks Consensus Estimate also moved higher. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.
ImmunoCellular Therapeutics currently carries a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Other well-performing biomedical stocks include Affymetrix Inc. (AFFX), ANI Pharmaceuticals, Inc. (ANIP) and Illumina Inc. (ILMN). All three sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment